Life Science Nation Newsletter  |  November 5, 2015  |  Issue 136

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (Oct. 29 - Nov. 4)
Investing Globally in Medical Devices
Seeking Opportunities Globally
Seeking Point-of-Care Diagnostics
Seeking Healthcare IT Opportunities
In This Issue
Early Stage Global Investors Converging on RESI@JPM

   READ MORE
RESI@JPM: Spotlight Your Firm at the RESI Innovation Challenge
       READ MORE
October Mandate Roundup

        READ MORE
LSN Videos
RESI Boston 2015 Investors Panel

Video Recap of RESI@TMCx 2015

  
Early Stage Global Investors Converging on RESI@JPM
By Dennis Ford, Founder & CEO, LSN

JPM week is a very busy time of year for the biotech and medtech industries. With investors' January schedules already filling up, it's important for entrepreneurs to get themselves in the right place at the right time in order to meet with the hundreds of investors who will be in San Francisco that week. That is how you create relationships that could lead to an allocation.

LSN's Redefining Early Stage Investments San Francisco event will be taking place on January 12th, 2016, and is shaping up to be the most dynamic yet in terms of investors already signing up. Evidently, investors are more organized than the rest of us! I am pleased to announce that RESI already has 150 investors from 16 countries registered to attend the event. This early trend is on track to surpass our most recent events in Boston and at TMCx in Houston in terms of investor turnout...

     READ MORE  

RESI@JPM: Spotlight Your Firm at the RESI Innovation Challenge
By Lucy Parkinson, Senior Research Manager, LSN

How will you make the most of your time in San Francisco in January? If you read our previous article, you'll know that over 300 investors will attend RESI on January 12th. The RESI Innovation Challenge provides entrepreneurs with a way to engage with this huge audience of active life science investors throughout the event.

The RESI Innovation Challenge showcases selected entrepreneurs in an exhibition-style format throughout the full-day conference. From the pool of applicants, LSN's internal scientific review board will choose the top 30 companies to present their technologies. Presenters will gain exposure to investors and potential partners by showcasing their companies and products in a poster board format in the RESI Exhibition Hall...

   READ MORE   
  
October Mandate Roundup
By Michael Quigley, Director of Research, LSN  

Last month, the research team at LSN spoke with 80 investors seeking to make allocations into privately held life science and healthcare companies. These investors spanned 16 countries, and while a majority were based in the United States, LSN found a significant investor presence spread all around the globe.

What is more interesting than where these investors are based, however, is where geographically they are willing to make allocations if the right opportunity were to arise...

    READ MORE